Dementia News and Research

Latest Dementia News and Research

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases.

6 May 2020

Study explores the impact of lockdown on older people with or without dementia

It has long been known that disrupted sleep can increase the risk of dementia and anecdotal evidence suggests COVID-19 anxiety is having a detrimental effect on sleep.

6 May 2020

Researchers develop AI algorithm to accurately predict risk for and diagnose Alzheimer's

Researchers have developed a computer algorithm based on Artificial Intelligence that can accurately predict the risk for and diagnose Alzheimer's disease using a combination of brain magnetic resonance imaging, testing to measure cognitive impairment, along with data on age and gender.

4 May 2020

As COVID-19 lurks, families are locked out of nursing homes. Is it safe inside?

Families are beset by fear and anxiety as COVID-19 makes inroads at nursing homes across the country, threatening the lives of vulnerable older adults.

4 May 2020

AI-based technology could help accelerate clinical trials for glaucoma

The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.

4 May 2020

Scripps professor receives Research Program Award for advancing RNA-targeting medicines

In recognition of his high-impact work advancing the field of RNA-targeting medicines, the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has awarded Scripps Research Chemistry Professor Matthew Disney, PhD, a prestigious Research Program Award, to aid Disney's development of treatments for incurable diseases such as Alzheimer's, Parkinson's, ALS and frontotemporal dementia.

4 May 2020

The medical consequences of anabolic-androgenic steroid use in men

A paper published in Psychotherapy and Psychosomatics, provides a careful analysis of the medical consequences of anabolic-androgenic steroid use in men.

30 Apr 2020

Study reveals how APOE4 triggers leaks in the blood-brain barrier

New USC research reveals how APOE4, a genetic culprit for Alzheimer's disease, triggers leaks in the brain's plumbing system, allowing toxic substances to seep into the brain areas responsible for memory encoding and other cognitive functions.

29 Apr 2020

Researchers identify a new risk factor for multiple neurodegenerative diseases

Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.

28 Apr 2020

Decreasing early neuroinflammation could slow Alzheimer's progression

In a new animal study examining Alzheimer's disease, researchers found that disease progression could be slowed by decreasing neuroinflammation in the brain before memory problems and cognitive impairment were apparent.

27 Apr 2020

National study looks at the impact of Covid-19 on older people, unpaid carers, and people with dementia

A new national study has been launched to look at the impact of social service closures due to coronavirus, on the lives of older people, people with dementia and unpaid carers.

27 Apr 2020

COVID-19 triggers adoption of telemedicine approaches to delivering neurology care

As COVID-19-related social isolation and distancing make it increasingly difficult for people with neurological conditions to access routine medical care, the crisis is transforming the way care is being delivered to these vulnerable individuals, according to neurology service providers.

24 Apr 2020

Study confirms that neuropeptide somatostatin can improve the brain’s cognitive function

Researchers have confirmed that neuropeptide somatostatin can improve cognitive function in the brain. A research group of Professor Seung-Hee Lee from the Department of Biological Sciences at KAIST found that the application of neuropeptide somatostatin improves visual processing and cognitive behaviors by reducing excitatory inputs to parvalbumin-positive interneurons in the cortex.

24 Apr 2020

Telehealth promises to be an affordable alternative for dementia care

Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.

23 Apr 2020

Scientists show how age-related hearing loss affects the brain

The brain doesn't cope well with age-related deafness and memory suffers.

23 Apr 2020

Study: Somatostatin treatment in cerebral cortex may improve visual processing, cognitive behaviors

23 Apr 2020

Researchers develop new blood test for Alzheimer's disease

A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg, Sweden. The method is based on measuring a specific variant of tau protein in ordinary blood samples, which makes the test relatively simple and cheap to perform.

23 Apr 2020